Clinical trial
Long-Term Specified Drug Use-results Survey of Betanis Tablets
NCT01901120 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Specified Drug Use-results Survey of Betanis Tablets
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- September 30, 2016
- Enrollment
- 1,263 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder